Evidence map›Paper›PMID 25491772›Full record

Trial reportScientific reports2014

Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung.

Ljubov Balabko, Katerina Andreev, Nadine Burmann, Melanie Schubert, Martina Mathews, Denis I Trufa, Sarah Reppert, Tilmann Rau, Martin Schicht, Horia Sirbu and 2 more

Open access · goldAbstract readClinical TrialComparative Study
In one paragraph

Trial report in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Ljubov BalabkoDepartment of Molecular Pneumology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Katerina AndreevDepartment of Molecular Pneumology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Nadine BurmannDepartment of Molecular Pneumology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Melanie SchubertDepartment of Molecular Pneumology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Martina MathewsDepartment of Molecular Pneumology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Denis I TrufaDepartment of Thoracic Surgery, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Sarah ReppertDepartment of Molecular Pneumology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Tilmann RauInstitute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Martin SchichtDepartment of Anatomy II, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Horia SirbuDepartment of Thoracic Surgery, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Arndt HartmannInstitute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Susetta FinottoDepartment of Molecular Pneumology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we describe increased expression of IL6R in the tumoural region of lung tissue from patients affected by lung adenocarcinoma as compared to squamous cell lung carcinoma. Moreover, here we found increased IL6R in the tumour free part of the lung. By using a murine model of lung adenocarcinoma, we discovered that few lung tumour cells expressed IL-6R and CD4+CD25+Foxp-3+ T regulatory cells down-regulated IL-6R in the tumour bearing lungs. Downstream of IL-6R, the Th17 lineage-specification factors: Signal transducer and activator of transcription 3 (STAT3), Basic leucine zipper transcription factor, BATF and a protein encoded by the RORC in human (RAR-related orphan receptor C) (RORγT), were also found induced in the tumoural region of lung tissue from patients affected by lung adenocarcinoma as compared to those carrying squamous cell carcinoma. Moreover, pSTAT3 protein was found phosphorylated and auto-phosphorylated in the tumoural region of patients with adeno cell carcinoma of the lung as compared to the tumoural region of patients with squamous cell carcinoma of the lung. Intranasal application of anti-IL-6R antibodies in a murine model of lung adenocarcinoma, induced T regulatory cell markers such as Foxp3, Ctla4, Icos, Il10, Il21, Folr4 and Lag3 and inhibited Rorc in lung adenocarcinoma.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overAnimalsBasic-Leucine Zipper Transcription FactorsCarcinoma, Squamous CellCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansLung NeoplasmsMaleMiceMiddle AgedNeoplasm ProteinsBasic-Leucine Zipper Transcription FactorsBATF protein, humanBatf protein, mouseIL6R protein, humanNeoplasm ProteinsNuclear Receptor Subfamily 1, Group F, Member 3Receptors, Interleukin-6RORC protein, humanSTAT3 protein, humanStat3 protein, mouseSTAT3 Transcription Factor

Identifiers

PMID25491772
PMCPMC4261178
OpenAlexW1986793275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.